Japan Capillary Blood Collection Devices Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Micro-Container Tubes, Micro-Hematocrit Tubes, Warming Devices, Lancing Devices, and Other Product Types), By Material (Plastic, Glass, and Other Materials), By Application (Glucose Monitoring, Hematocrit Testing, Cholesterol Testing, Coagulation Testing, and Other Applications), and Japan Capillary Blood Collection Devices Market Insights, Industry Trend, Forecasts to 2035
Industry: HealthcareJapan Capillary Blood Collection Devices Market Insights Forecasts to 2035
- The Japan Capillary Blood Collection Devices Market Size Was Estimated at USD 99.6 Million in 2024
- The Market Size is Expected to Grow at a CAGR of around 9.7% from 2025 to 2035
- The Japan Capillary Blood Collection Devices Market Size is Expected to Reach USD 275.8 Million by 2035
Get more details on this report -
According to a research report published by Spherical Insights & Consulting, the Japan capillary blood collection devices market is anticipated to reach USD 275.8 million by 2035, growing at a CAGR of 9.7% from 2025 to 2035. The market for Japan capillary blood collection devices is growing due to the increasing chronic diseases, the need for minimally invasive procedures, and awareness of rapid diagnostic testing, fueled by technologies that provide safer, convenient, and effective collection devices.
Market Overview
The Japan capillary blood collection device market is defined as instruments, including lancets, micro container tubes, warmers, and dried blood spot cards, aimed at minimally invasive collection of small amounts of blood through capillary sampling, usually from fingerprints or heels. They are applied in areas such as glucose testing, infectious disease testing, cholesterol testing, neonatal screening, and therapeutic drug monitoring in both hospital settings and increasingly in home use. Japan strong healthcare infrastructure, high awareness of preventive monitoring, and established diagnostics industry support market resilience. Opportunities lie in the expansion of at home care, partnerships with laboratories and pharmaceutical companies, and integration of digital connectivity in the collection systems. Growth factors for this market include an aging Japanese population and a growing epidemic or chronic disease burden, which will fuel demand for convenient, more frequent testing, a preventive healthcare focus, and expanding rapid diagnostic and home diagnostic testing. Government policies on health monitoring and alleviating healthcare burdens in an aging population, combined with advanced device adoption support, further boost market growth.
Report Coverage
This research report categorizes the market for the Japan capillary blood collection devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan capillary blood collection devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan capillary blood collection devices market.
Japan Capillary Blood Collection Devices Market Report Coverage
Report Coverage | Details |
---|---|
Base Year: | 2024 |
Market Size in 2024: | USD 99.6 Million |
Forecast Period: | 2025-2035 |
Forecast Period CAGR 2025-2035 : | 9.7% |
2035 Value Projection: | USD 2478.98 Million |
Historical Data for: | 2020-2023 |
No. of Pages: | 165 |
Tables, Charts & Figures: | 89 |
Segments covered: | By Product, By Material, By Application, and COVID-19 Impact Analysis |
Companies covered:: | Terumo Corporation, Haemonetics Corporation, Nipro Medical Corporation, Medtronic plc, FL Medical, Greiner Bio-One, Thermo Fisher Scientific, Owen Mumford Ltd, Sekisui Medical Co., Ltd., Becton Dickinson, Abbott Laboratories, Improve Medical Instruments Co., Ltd., Others, and others key players |
Pitfalls & Challenges: | COVID-19 Empact, Challenges, Future, Growth, & Analysis |
Get more details on this report -
Driving Factors
The Japan capillary blood collection devices market is driven by a rising elderly population, a surge in chronic conditions such as diabetes, and increasing demand for minimally invasive diagnostic methods. The trend toward preventive healthcare and home testing further drives market growth. Technological advancements in microsampling, convenient, introspection kits, and dried blood spot (DBS) techniques improve usability and accuracy. Additionally, strong healthcare infrastructure and heightened public awareness of early disease detection contribute to the increasing adoption of these devices across Japan.
Restraining Factors
The market of Japan capillary blood collection devices is constrained by restricted blood volume for advanced testing, risk of sample contamination, and differences in results. Regulatory problems and the unavailability of qualified personnel to handle samples properly may also deter extensive usage.
Market Segmentation
The Japan capillary blood collection devices market share is classified into product type, material, and application.
- The lancing devices segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Japan capillary blood collection devices market is segmented by product type into micro-container tubes, micro-hematocrit tubes, warming devices, lancing devices, and other product types. Among these, the lancing devices segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to their improvement in the user experience through pain reduction and optimized blood collection efficiency. Technological advancements involve adjustable depth control and precision-guided lancing. Integration with glucose monitors, with Bluetooth connectivity, facilitates real-time tracking of data for a seamless, convenient monitoring experience.
- The plastic segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Japan capillary blood collection devices market is segmented by material into plastic, glass, and other materials. Among these, the plastic segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is owing to the innovations in plastic compounds, such as advanced polypropylene formulations, which are upgrading capillary blood collection devices by adding toughness, flexibility, and sterilization compatibility. Along with this is the expanding application of biocompatible materials, which increases patient safety through lower adverse reactions, trendsetter, safer, and more effective designs.
- The glucose monitoring segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.
The Japan capillary blood collection devices market is segmented by application into glucose monitoring, hematocrit testing, cholesterol testing, coagulation testing, and other applications. Among these, the glucose monitoring segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Capillary blood sampling devices are central to diabetes care, facilitating frequent monitoring of glucose levels. These devices consist of lancing devices, capillary tubes, and glucose meters. Increasing focus on convenience has led to developments, such that these devices are becoming more accessible and easily available for patients to monitor their blood glucose levels.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the Japan capillary blood collection devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Terumo Corporation
- Haemonetics Corporation
- Nipro Medical Corporation
- Medtronic plc
- FL Medical
- Greiner Bio-One
- Thermo Fisher Scientific
- Owen Mumford Ltd
- Sekisui Medical Co., Ltd.
- Becton Dickinson
- Abbott Laboratories
- Improve Medical Instruments Co., Ltd.
- Others
Recent Developments:
- In December 2024, BD and Babson Diagnostics announced plans to expand fingertip blood collection and testing technologies for U.S. health systems, urgent cares, and ambulatory settings. This innovation combines BD’s MiniDraw™ Capillary Blood Collection System with Babson’s BetterWay technology, enabling accurate test results from just six drops of capillary blood collected from a patient’s finger.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan capillary blood collection devices market based on the below-mentioned segments:
Japan Capillary Blood Collection Devices Market, By Product Type
- Micro-Container Tubes
- Micro-Hematocrit Tubes
- Warming Devices
- Lancing Devices
- Other Product Types
Japan Capillary Blood Collection Devices Market, By Material
- Plastic
- Glass
- Other Materials
Japan Capillary Blood Collection Devices Market, By Application
- Glucose Monitoring
- Hematocrit Testing
- Cholesterol Testing
- Coagulation Testing
- Other Applications
Need help to buy this report?